A five-month public awareness campaign significantly improved people's knowledge of stroke warning signs, with a notable increase in awareness among women. In contrast, men showed little change in their understanding of stroke warning signs.
A nationwide clinical trial involving nearly 400 patients showed no statistically significant difference in full recovery and mortality rates between those given citicoline and a placebo. However, the drug appeared to produce an improvement in a subset of patients with moderate to severe strokes.
Researchers found that a vitamin supplement with folic acid, B-6, and B-12 reduced homocysteine levels and improved biochemical markers in the blood of 27 patients who had suffered a stroke. The study suggests that lowering homocysteine may have multiple biological effects on endothelial cells.
A study found that pravastatin significantly reduced the risk of stroke or ministroke in heart attack survivors by 32% compared to those who received a placebo. The medication also lowered the risk of either strokes or transient ischemic attacks (TIAs) by 27%.